CVS to buy specialty drug infusion business for $2.1 billion – Reuters

CVS to buy specialty drug infusion business for $2.1 billionReutersN) will buy drug infusion services provider Coram LLC for $2.1 billion, allowing the company to bolster its pharmacy benefits management business by offering cost-effective delivery of …

CVS to buy specialty drug infusion business for $2.1 billion
Reuters
N) will buy drug infusion services provider Coram LLC for $2.1 billion, allowing the company to bolster its pharmacy benefits management business by offering cost-effective delivery of specialty drugs. Most pharma companies are increasingly focused on 
CVS Inks $2.1B Buyout of Specialty Infusion Business CoramFox Business
CVS Caremark to Buy Infusion BusinessNew York Times

all 140 news articles »

Please follow and like us:

http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNGSsOj4ZsRy2KwkeZ-5A4AWcmSWmQ&url=http://www.reuters.com/article/2013/11/27/us-cvscaremark-apria-idUSBRE9AQ0NZ20131127

[original_link]
Source

business news - Google News
http://news.google.com/news?pz=1&ned=us&hl=en&q=business+news
http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNGSsOj4ZsRy2KwkeZ-5A4AWcmSWmQ&url=http://www.reuters.com/article/2013/11/27/us-cvscaremark-apria-idUSBRE9AQ0NZ20131127
http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNGSsOj4ZsRy2KwkeZ-5A4AWcmSWmQ&url=http://www.reuters.com/article/2013/11/27/us-cvscaremark-apria-idUSBRE9AQ0NZ20131127
Cornelius Rupert T.
Cornelius Rupert T.